Nrx Pharmaceuticals Inc (NRXP)

$2.15 +0.02 (0.94%)
Market Cap 65.72M
Revenue (ttm) 0.00
Net Income (ttm) -25.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 12.00
Profit Margin 0.00%
Debt to Equity Ratio -0.39
Volume 21,977,301
Avg Vol 524,886
Day's Range N/A - N/A
Shares Out 29.61M
Stochastic %K 9%
Beta 1.62
Analysts Strong Sell
Price Target $36.75

Company Profile

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-f...

Industry: Biotechnology
Sector: Healthcare
Phone: 484 254 6134
Address:
1201 Orange Street, Suite 600, Wilmington, United States
MoneyGroupLLC
MoneyGroupLLC Jan. 14 at 9:41 PM
Enter: $NRXP Calls Strike Price: $2 Expiry Date: FEB 20 2026 Buy in Price: $0.40 - $4.80 Sell Price: $0.67 Profit : +68% (Turn every $1 into $1.68) Want Profitable Real-Time Options Alerts? šŸ‘‰ https://moneygroup.us/
0 Ā· Reply
jonny80s
jonny80s Jan. 14 at 9:24 PM
$NRXP 22mil shares to gain $0.02ā€¦. Winner, winner, chicken dinner!
1 Ā· Reply
mary46
mary46 Jan. 14 at 9:10 PM
$NRXP im not buying this crapper unless institutional investors start buying
0 Ā· Reply
NetworkNewsWire
NetworkNewsWire Jan. 14 at 8:50 PM
PsychedelicNewsBreaks ā€“ $NRXP Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100 https://ibn.fm/rVxpY
0 Ā· Reply
budd420
budd420 Jan. 14 at 8:32 PM
$NRXP $30 coming soon šŸ¤
1 Ā· Reply
DonDon531
DonDon531 Jan. 14 at 8:26 PM
$NRXP canā€™t help to laugh at what this one minute BBand chart looks like. Perhaps we get an explosion upwards!!!! šŸ˜‚
0 Ā· Reply
jonny80s
jonny80s Jan. 14 at 8:19 PM
$NRXP are we thinking 10mil share offering ATM premarket? Why now, besides the fact that it is the exact 1yr anniversary of the end of last years pump. SEC filing by 5:30pm.
1 Ā· Reply
RichTheKing
RichTheKing Jan. 14 at 8:02 PM
$NRXP wow 21,5 millions
1 Ā· Reply
WolfOf_MyStreet
WolfOf_MyStreet Jan. 14 at 7:59 PM
$NRXP the next catalyst is FDA response and feedback on today's submission. If the FDA accepts this data instead of a phase 3 trial then we are in the clear. I can't see how they would not as this provides much more evidence than a trial would.
0 Ā· Reply
MoneyToSpread
MoneyToSpread Jan. 14 at 7:43 PM
@StrategistBrady been putting out some good stuff lately. Been catching a few of the setups myselfšŸ’Æ If you trade, keep him on your radar and give him a follow. $VZ $LITE $NRXP $ANET Good to enter
0 Ā· Reply
Latest News on NRXP
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

Jan 14, 2026, 7:03 AM EST - 12 hours ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions

Jan 5, 2026, 6:57 AM EST - 9 days ago

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

Dec 18, 2025, 7:05 AM EST - 27 days ago

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation

Dec 3, 2025, 7:00 AM EST - 6 weeks ago

NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation

NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation Transcript

Dec 2, 2025, 11:23 AM EST - 6 weeks ago

NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation Transcript

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREEā„¢, a Preservative-Free IV Ketamine

Dec 2, 2025, 8:30 AM EST - 6 weeks ago

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREEā„¢, a Preservative-Free IV Ketamine

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call

Dec 2, 2025, 7:30 AM EST - 6 weeks ago

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference

Dec 1, 2025, 8:03 AM EST - 6 weeks ago

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference

NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript

Nov 17, 2025, 11:57 AM EST - 2 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 17, 2025, 8:03 AM EST - 2 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025

Nov 12, 2025, 8:31 AM EST - 2 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025

HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health

Nov 10, 2025, 8:03 AM EST - 2 months ago

HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

Oct 20, 2025, 8:03 AM EDT - 3 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

Oct 6, 2025, 8:03 AM EDT - 3 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREEā„¢, Preservative-Free IV Ketamine

Sep 29, 2025, 8:03 AM EDT - 3 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREEā„¢, Preservative-Free IV Ketamine

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)Ā Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine

Sep 24, 2025, 8:03 AM EDT - 4 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)Ā Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

Sep 8, 2025, 8:17 AM EDT - 4 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat atĀ H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

Sep 3, 2025, 8:03 AM EDT - 4 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat atĀ H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)Ā Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

Sep 2, 2025, 1:19 PM EDT - 4 months ago

UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)Ā Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)Ā Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

Sep 2, 2025, 8:41 AM EDT - 4 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)Ā Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)Ā Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

Aug 27, 2025, 8:03 AM EDT - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)Ā Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

NRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call Transcript

Aug 20, 2025, 12:23 PM EDT - 5 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 18, 2025, 8:10 AM EDT - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

Aug 13, 2025, 6:06 PM EDT - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

Aug 11, 2025, 4:05 PM EDT - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression

Aug 11, 2025, 8:03 AM EDT - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA)

Aug 8, 2025, 8:03 AM EDT - 5 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products

Aug 4, 2025, 8:03 AM EDT - 5 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025

Jul 29, 2025, 8:03 AM EDT - 6 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 - 30, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics

Jun 26, 2025, 8:03 AM EDT - 7 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100)

Jun 23, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100)

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners

Jun 16, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Jun 12, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine

Jun 5, 2025, 8:03 AM EDT - 7 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript

May 16, 2025, 8:46 PM EDT - 8 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 15, 2025, 4:03 PM EDT - 8 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update

HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions

May 15, 2025, 10:15 AM EDT - 8 months ago

HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics

May 13, 2025, 8:03 AM EDT - 8 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025

May 12, 2025, 8:03 AM EDT - 8 months ago

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025

May 6, 2025, 8:03 AM EDT - 9 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV Ketamine

May 5, 2025, 8:03 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV Ketamine

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression

Apr 30, 2025, 8:46 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeuticsā„¢, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025

Apr 21, 2025, 8:01 AM EDT - 9 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeuticsā„¢, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE

Apr 3, 2025, 8:03 AM EDT - 10 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical; Initial Acquisition for Planned International Network of Interventional Psychiatry Clinics

Mar 31, 2025, 8:02 AM EDT - 10 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical; Initial Acquisition for Planned International Network of Interventional Psychiatry Clinics

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics

Mar 24, 2025, 8:02 AM EDT - 10 months ago

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics

NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript

Mar 17, 2025, 10:50 AM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 17, 2025, 8:02 AM EDT - 10 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 17, 2025

Mar 12, 2025, 8:01 AM EDT - 11 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 17, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeuticsā„¢, Inc. to Present at the Oppenheimer 35th Annual Healthcare Conference on February 12, 2025

Feb 6, 2025, 8:03 AM EST - 1 year ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeuticsā„¢, Inc. to Present at the Oppenheimer 35th Annual Healthcare Conference on February 12, 2025

MoneyGroupLLC
MoneyGroupLLC Jan. 14 at 9:41 PM
Enter: $NRXP Calls Strike Price: $2 Expiry Date: FEB 20 2026 Buy in Price: $0.40 - $4.80 Sell Price: $0.67 Profit : +68% (Turn every $1 into $1.68) Want Profitable Real-Time Options Alerts? šŸ‘‰ https://moneygroup.us/
0 Ā· Reply
jonny80s
jonny80s Jan. 14 at 9:24 PM
$NRXP 22mil shares to gain $0.02ā€¦. Winner, winner, chicken dinner!
1 Ā· Reply
mary46
mary46 Jan. 14 at 9:10 PM
$NRXP im not buying this crapper unless institutional investors start buying
0 Ā· Reply
NetworkNewsWire
NetworkNewsWire Jan. 14 at 8:50 PM
PsychedelicNewsBreaks ā€“ $NRXP Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100 https://ibn.fm/rVxpY
0 Ā· Reply
budd420
budd420 Jan. 14 at 8:32 PM
$NRXP $30 coming soon šŸ¤
1 Ā· Reply
DonDon531
DonDon531 Jan. 14 at 8:26 PM
$NRXP canā€™t help to laugh at what this one minute BBand chart looks like. Perhaps we get an explosion upwards!!!! šŸ˜‚
0 Ā· Reply
jonny80s
jonny80s Jan. 14 at 8:19 PM
$NRXP are we thinking 10mil share offering ATM premarket? Why now, besides the fact that it is the exact 1yr anniversary of the end of last years pump. SEC filing by 5:30pm.
1 Ā· Reply
RichTheKing
RichTheKing Jan. 14 at 8:02 PM
$NRXP wow 21,5 millions
1 Ā· Reply
WolfOf_MyStreet
WolfOf_MyStreet Jan. 14 at 7:59 PM
$NRXP the next catalyst is FDA response and feedback on today's submission. If the FDA accepts this data instead of a phase 3 trial then we are in the clear. I can't see how they would not as this provides much more evidence than a trial would.
0 Ā· Reply
MoneyToSpread
MoneyToSpread Jan. 14 at 7:43 PM
@StrategistBrady been putting out some good stuff lately. Been catching a few of the setups myselfšŸ’Æ If you trade, keep him on your radar and give him a follow. $VZ $LITE $NRXP $ANET Good to enter
0 Ā· Reply
Stocksqueezee
Stocksqueezee Jan. 14 at 7:43 PM
$NRXP add buy now
0 Ā· Reply
Stocksqueezee
Stocksqueezee Jan. 14 at 7:31 PM
$NRXP after market up???
0 Ā· Reply
Stocksqueezee
Stocksqueezee Jan. 14 at 7:30 PM
$NRXP buy
0 Ā· Reply
DavidBG
DavidBG Jan. 14 at 7:25 PM
$NRXP The latest earnings release said that the NDA for NRX-100 would "be completed" with the addition of this RWE data set, meaning that the French government data, NIH data, and PCORI data have already been submitted. Good times coming.
0 Ā· Reply
jonny80s
jonny80s Jan. 14 at 7:14 PM
$NRXP and people wonder why we arenā€™t on the CNPV award list. Lol
0 Ā· Reply
Trending__Now
Trending__Now Jan. 14 at 7:12 PM
$NRXP The world may be resetting but we hit a buy range of $2-$2.20. Nice volume so I trust shorts are beginning to cover. Games, lots of games. Tagging $2.07 for swing play over the next month.
0 Ā· Reply
vokomah730
vokomah730 Jan. 14 at 6:47 PM
$NRXP https://x.com/AlexBass50/status/2011502056843149388
0 Ā· Reply
Stocksqueezee
Stocksqueezee Jan. 14 at 6:46 PM
$NRXP
0 Ā· Reply
jonny80s
jonny80s Jan. 14 at 6:45 PM
$NRXP does this mean that I was right the entire time and that Javittā€™s ā€œFrenchā€ data has always been worthless? And that he has been lying since day 1 concerning the timeline for the NDA submission??? We all knew he has been lying about the timeline. But this new development really puts it into focus.
0 Ā· Reply
fuctonfauci
fuctonfauci Jan. 14 at 6:23 PM
$NRXP For whom did the honest long-term shareholders have to bend over today?
0 Ā· Reply
Adamchristlover
Adamchristlover Jan. 14 at 6:08 PM
$NRXP Loaded 50 K shares at 2 bucks earlier holding them for two years.
2 Ā· Reply
DonDon531
DonDon531 Jan. 14 at 5:50 PM
$NRXP May soon pop on the 5 minuteā€¦ā€¦
0 Ā· Reply